Summit Therapeutics
SMMT
$3.92
Share price
1.42%
Change (1 day)
196.59%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Cash on Hand
Cash on Hand as of December 2023 : $0.18 B
According to Summit Therapeutics
's latest financial reports the company has $0.18 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.18 B | -46.58% |
| 2022-12-31 | $0.34 B | 385.59% |
| 2021-12-31 | $71.79 M | 8.09% |
| 2020-12-31 | $66.41 M | |
| 2019-01-31 | $46.2 M | 14.72% |
| 2018-01-31 | $40.27 M | -8.13% |
| 2017-01-31 | $43.84 M | 32.55% |
| 2016-01-31 | $33.07 M | 29.18% |
| 2015-01-31 | $25.6 M | 363.52% |
| 2014-01-31 | $5.52 M | -34.48% |
| 2013-01-31 | $8.43 M | 64.65% |
| 2012-01-31 | $5.12 M | -37.1% |
| 2011-01-31 | $8.14 M | -47.48% |
| 2010-01-31 | $15.5 M | 178.51% |
| 2009-01-31 | $5.56 M | -86.06% |
| 2008-01-31 | $39.93 M | -43.31% |
| 2007-01-31 | $70.43 M | 75.59% |
| 2006-01-31 | $40.11 M | -20.15% |
| 2005-01-31 | $50.23 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.67 B | 800.04% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $18.87 M | -89.87% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.11 B | -36.78% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |